(1)
M. Kamil, M.; Jabarah, M. A.-. H.; A.l. Jasim, N. Immunogenicity of the Biosimilar CT-P13 Infliximab or the Original Infliximab in Iraqi Patients With Ankylosing Spondylitis Does Not Correlate With Their Demographic Characteristics. JFacMedBagdad 2023, 64 (4), 261-267. https://doi.org/10.32007/jfacmedbagdad.6441969.